Vaccines, blood, antisera, toxins and cultures in   Austria

Exports In 2021, Austria exported $7.24B in Vaccines, blood, antisera, toxins and cultures, making it the 12th largest exporter of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 1st most exported product in Austria. The main destination of Vaccines, blood, antisera, toxins and cultures exports from Austria are: Germany ($2.06B), United States ($876M), Poland ($787M), Belgium ($631M), and Italy ($451M).

The fastest growing export markets for Vaccines, blood, antisera, toxins and cultures of Austria between 2020 and 2021 were Germany ($1.45B), United States ($236M), and China ($155M).

Imports In 2021, Austria imported $5.5B in Vaccines, blood, antisera, toxins and cultures, becoming the 14th largest importer of Vaccines, blood, antisera, toxins and cultures in the world. At the same year, Vaccines, blood, antisera, toxins and cultures was the 3rd most imported product in Austria. Austria imports Vaccines, blood, antisera, toxins and cultures primarily from: United States ($1.36B), Germany ($967M), China ($947M), Switzerland ($530M), and Italy ($390M).

The fastest growing import markets in Vaccines, blood, antisera, toxins and cultures for Austria between 2020 and 2021 were China ($873M), United States ($295M), and Germany ($176M).

Tariffs In 1990, the average tariff for Austria in Vaccines, blood, antisera, toxins and cultures was 4.18%. The countries with the highest import tariffs for Vaccines, blood, antisera, toxins and cultures were Mayotte (Most Favoured Nation duty rate treatment, 7.08%), South Sudan (Most Favoured Nation duty rate treatment, 7.08%), South Africa (Most Favoured Nation duty rate treatment, 7.08%), Antarctica (Most Favoured Nation duty rate treatment, 7.08%), and French South Antarctic Territory (Most Favoured Nation duty rate treatment, 7.08%).